The clinical trial landscape has shifted as a result of COVID-19 and quality risk management techniques and tools have evolved by leaps and bounds over the last year. Best practices in RBQM are influencing clinical study methodology and decentralized trials, putting a spotlight on risk based data review including site and central monitoring.
DGE invites you to attend the 4th Risk-Based Quality Management Summit and hear from industry experts on how elements of RBQM can be implemented individually and independently to great success, making clinical trials better, faster, cheaper, and safer for patients.
